FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections
Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment
No New Adverse Events Reported for DTaP Vaccination
Most frequently reported adverse events included injection site erythema and swelling, pyrexia
May 2018 Briefing – Infectious Disease
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2018. This roundup includes the...
Fever, Rash, Erythema Seen in Most Puerto Rican Kids With Zika
Median serum viral load varies significantly according to number of days after symptom onset
CDC Says E. Coli Outbreak Tied to Romaine Lettuce Is Over
197 cases of illness linked to the E. coli outbreak, five of which were fatal
ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
FDA Issues Final Guidance on Inhalational Anthrax
Final guidance designed to assist in development of drugs for prophylaxis of inhalational anthrax
Children Typically Have 14 Simple Infections by Age 3 Years
Environmental exposures explain only a small fraction of the variation in infections
Most Premature Infants Receive Early Antibiotics
Variation across centers in early antibiotic exposures, prolonged antibiotic administration
